We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.48B
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.65% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HARP
1476
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $455K | ﹤0.01% |
9,158
-3,622
| -28% | -$188K |
|
1477
Equitable Holdings
EQH
$14.7B
| $446K | ﹤0.01% |
14,422
+2,854
| +25% | +$94.1K |
|
1478
Organon & Co
OGN
$3.59B
| $446K | ﹤0.01% |
12,730
+3,806
| +43% | +$130K |
|
1479
AGNC Investment
AGNC
$11.7B
| $443K | ﹤0.01% |
33,802
+8,908
| +36% | +$125K |
|
1480
Mirum Pharmaceuticals
MIRM
$6.32B
| $440K | ﹤0.01% |
+19,985
| New | +$408K |
|
1481
Viasat
VSAT
$9.77B
| $439K | ﹤0.01% |
8,995
+756
| +9% | +$34.8K |
|
|
ROCC
1482
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $437K | ﹤0.01% |
12,663
-1,390
| -10% | -$45.4K |
|
1483
Spire
SR
$4.72B
| $436K | ﹤0.01% |
6,073
+198
| +3% | +$13.1K |
|
1484
Gen Digital
GEN
$18.3B
| $435K | ﹤0.01% |
16,392
-680
| -4% | -$18.7K |
|
1485
Sabre
SABR
$936M
| $432K | ﹤0.01% |
37,782
+7,800
| +26% | +$76.4K |
|
1486
NewMarket
NEU
$8.2B
| $430K | ﹤0.01% |
1,325
-29
| -2% | -$9.5K |
|
1487
Minerals Technologies
MTX
$2.15B
| $428K | ﹤0.01% |
6,464
+68
| +1% | +$4.7K |
|
1488
Peoples Bancorp
PEBO
$1.42B
| $426K | ﹤0.01% |
13,611
+1,716
| +14% | +$55.7K |
|
|
FISV
1489
Fiserv Inc
FISV
$26.3B
| $424K | ﹤0.01% |
4,178
-1,990
| -32% | -$201K |
|
1490
Fastenal
FAST
$56.3B
| $423K | ﹤0.01% |
14,230
+4,052
| +40% | +$113K |
|
|
TGI
1491
DELISTED
Triumph Group
TGI
| $423K | ﹤0.01% |
16,743
-1,837
| -10% | -$40.8K |
|
1492
Schrodinger
SDGR
$1.79B
| $422K | ﹤0.01% |
+12,381
| New | +$376K |
|
1493
Arthur J. Gallagher & Co
AJG
$62.5B
| $420K | ﹤0.01% |
2,408
+1,703
| +242% | +$272K |
|
|
TBI
1494
Trueblue
TBI
$276M
| $416K | ﹤0.01% |
14,413
| – | – |
|
1495
Western Alliance Bancorporation
WAL
$8.49B
| $416K | ﹤0.01% |
5,018
+4,997
| +23,795% | +$489K |
|
|
ESGR
1496
DELISTED
Enstar Group
ESGR
| $414K | ﹤0.01% |
1,584
| – | – |
|
1497
Ralph Lauren
RL
$20.2B
| $413K | ﹤0.01% |
3,637
+3,519
| +2,982% | +$415K |
|
1498
TransDigm Group
TDG
$59.7B
| $411K | ﹤0.01% |
631
-62
| -9% | -$39.8K |
|
1499
International Bancshares
IBOC
$4.41B
| $409K | ﹤0.01% |
9,691
-532
| -5% | -$22.8K |
|
1500
IBEX
IBEX
$535M
| $402K | ﹤0.01% |
25,206
-82,794
| -77% | -$1.23M |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.